Bottom line
DLRHX vs VHT: the short answer
DLRHX (Nomura Healthcare Fund) and VHT (Vanguard Health Care Index Fund) are both mutual funds.
But VHT is far broader, holding 407 positions to 108 for DLRHX, so beyond the top names it adds exposure DLRHX doesn't have.
VHT is cheaper at 0.09% vs 1.46% — a difference of $137 a year per $10,000 invested.
Over five years, DLRHX returned +7.2% a year vs +7.2% for VHT (reporting dates differ).
Updated Nov 19, 2026
DLRHX vs VHT side by side
| DLRHX | VHT | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Voya | Vanguard |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.46% | 0.09% |
| Annual cost per $10k | $146 | $9 |
| 10-yr cost on $10k (prospectus) | $1,797 | $115 |
| Max front load | 0% | None |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +21.8% | +2.7% |
| 5-yr return (annualized) | +7.2% | +7.2% |
| 10-yr return (annualized) | +9.9% | +8.8% |
| Best quarter | — | +16.5% |
| Worst quarter | — | −13.1% |
| Net assets (fund) | $750.2M | $19.0B |
| Number of holdings | 108 | 407 |
| Portfolio turnover | 4% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of DLRHX's top 25 holdings also appear in VHT's top 25.
| Holding | DLRHX | VHT |
|---|---|---|
| Abbvie Inc | 4.19% | 6.09% |
| Eli Lilly & Company | 4.16% | 14.04% |
| Regeneron Pharmaceuticals Inc | 3.91% | 1.00% |
| Unitedhealth Group Inc | 3.88% | 5.45% |
| Pfizer Inc | 3.84% | 2.35% |
| Merck & Company Inc | 3.68% | 4.66% |
| Gilead Sciences Inc | 3.54% | 2.64% |
| Elevance Health Inc | 3.25% | 1.35% |
| Amgen Inc | 2.27% | 2.87% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.80% |
| Boston Scientific Corp | 1.42% | 1.13% |
Source: SEC Form N-PORT
DLRHX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
VHT top 10
- Eli Lilly & Co — 14.04%
- Johnson & Johnson — 8.47%
- AbbVie Inc — 6.09%
- UnitedHealth Group Inc — 5.45%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 2.93%
- Amgen Inc — 2.87%
- Gilead Sciences Inc — 2.64%
- Intuitive Surgical Inc — 2.38%
- Pfizer Inc — 2.35%
FAQ
What is the difference between DLRHX and VHT?
Which is cheaper, DLRHX or VHT?
Should I own both DLRHX and VHT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.